Precision BioPharma
Precision BioPharma Inc. (PBI) is an innovative next-generation drug development company focused on rapid drug discovery and development. Leveraging an Adaptive Translational Research approach and AI-driven research processes, they specialize in antiviral drug discovery, development, and repurposing, aiming to reduce the time and cost associated with bringing drugs to market. The company boasts a strong team of experts in artificial intelligence, genomics, drug discovery, development, clinical trials, and regulatory affairs, with over 300 years of cumulative experience. PBI has a rich pipeline of early and late-stage assets, including a lead molecule PB004 for which they have submitted a pre-IND application to the US FDA. They also emphasize strategic partnerships to aid in clinical trials and scaling, positioning themselves as a leader in advancing healthcare through precision medicine.
Precision BioPharma
Precision BioPharma Inc. (PBI) is an innovative next-generation drug development company focused on rapid drug discovery and development. Leveraging an Adaptive Translational Research approach and AI-driven research processes, they specialize in antiviral drug discovery, development, and repurposing, aiming to reduce the time and cost associated with bringing drugs to market. The company boasts a strong team of experts in artificial intelligence, genomics, drug discovery, development, clinical trials, and regulatory affairs, with over 300 years of cumulative experience. PBI has a rich pipeline of early and late-stage assets, including a lead molecule PB004 for which they have submitted a pre-IND application to the US FDA. They also emphasize strategic partnerships to aid in clinical trials and scaling, positioning themselves as a leader in advancing healthcare through precision medicine.